Trials / Completed
CompletedNCT03902301
Lactobacillus Rhamnosus and PCOS Treatment
The Effect of Lactobacillus Rhamnosus Supplementation on Body Mass, Hyperandrogenism and Insulin Resistance in Overweight and Obese Polycystic Ovary Syndrome Women - Randomized Nutritional Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Poznan University of Life Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The effect of Lactobacillus rhamnosus supplementation on body weight, hyperandrogenism and insulin resistance in overweight and obesity women with Polycystic Ovary Syndrome will be analysed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus group | Nutrition intervention focused on the treatment of insulin resistance + Lactobacillus rhamnosus supplementation (6x10 9 of lactobacillus rhamnosus x 2 times a day) (35 people). |
| DIETARY_SUPPLEMENT | Dietary group | Nutritional intervention focused on the treatment of insulin resistance (35 subjects). |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-04-04
- Last updated
- 2022-04-26
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03902301. Inclusion in this directory is not an endorsement.